Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
ACP has acquired Heritage Imaging, a medical devices business in New York. Heritage Imaging designs and supports imaging technology used in clinical settings, strengthening ACP’s healthcare M&A footprint in NY acquisitions. The add-on acquisition is expected to expand ACP acquisitions capabilities in medical devices acquisition and broaden service offerings for healthcare providers. ACP, a private equity buyer, is pursuing this add on acquisition as an add-on acquisition strategy, with Heritage Imaging led by CEO Dr. Steve Coppess and current management continuing post-close. Deal size was not disclosed, and the acquisition was announced with terms not publicly detailed.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026